1. Home
  2. Southern Africa
  3. South Africa

Heat-resistant AIDS drug on way

US drug giant Abbott Laboratories on Tuesday filed for South African registration of a heat-resistant tablet version of its anti-AIDS drug, Kaletra.

Abbott's move comes about a month after protests over the company withholding the drug from developing countries, where refrigerated liquid versions were still being used.

The new version of Kaletra - a key second-line treatment for HIV-positive people who develop resistance to, or side effects from, first-line treatments - received approval in the US in October 2005, but was not shipped to developing countries.

"We are trying to do everything we can to investigate registrations in other developing countries," Abbott spokeswoman Melissa Brotz said in a statement, adding that South African approval would only come in the third quarter of 2007.


This article was produced by IRIN News while it was part of the United Nations Office for the Coordination of Humanitarian Affairs. Please send queries on copyright or liability to the UN. For more information: https://shop.un.org/rights-permissions

Share this article

Our ability to deliver compelling, field-based reporting on humanitarian crises rests on a few key principles: deep expertise, an unwavering commitment to amplifying affected voices, and a belief in the power of independent journalism to drive real change.

We need your help to sustain and expand our work. Your donation will support our unique approach to journalism, helping fund everything from field-based investigations to the innovative storytelling that ensures marginalised voices are heard.

Please consider joining our membership programme. Together, we can continue to make a meaningful impact on how the world responds to crises.

Become a member of The New Humanitarian

Support our journalism and become more involved in our community. Help us deliver informative, accessible, independent journalism that you can trust and provides accountability to the millions of people affected by crises worldwide.

Join